Cargando…
Plasma kallistatin levels in patients with severe community-acquired pneumonia
INTRODUCTION: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) treatment commonly causes acute respiratory failure with high mortality. Kallistatin, an endogenous tissue kallikrein inhibitor, has been reported to be protective in various human diseases. The aim of this study wa...
Autores principales: | Lin, Wei-Chieh, Lu, Shiou-Ling, Lin, Chiou-Feng, Chen, Chang-Wen, Chao, Lee, Chao, Julie, Lin, Yee-Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056893/ https://www.ncbi.nlm.nih.gov/pubmed/23394256 http://dx.doi.org/10.1186/cc12507 |
Ejemplares similares
-
Plasma kallistatin in critically ill patients with severe sepsis and septic shock
por: Lin, Wei-Chieh, et al.
Publicado: (2017) -
Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis
por: Lin, Wei-Chieh, et al.
Publicado: (2015) -
Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
por: Yao, Yuyu, et al.
Publicado: (2018) -
Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017) -
Crystallization and crystallographic studies of kallistatin
por: Lin, Fang, et al.
Publicado: (2015)